Cite
HARVARD Citation
Schwarting, A. et al. (2016). First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study. Rheumatology and therapy. 3 (2), pp. 271-290. [Online].